Literature DB >> 28848897

Veterans Airflow Obstruction Screening Questionnaire: A Survey to Identify Veterans with Airflow Obstruction.

Folarin Sogbetun1, Wlliam L Eschenbacher1,2, Jeffrey A Welge3, Ralph J Panos1,2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality within the Veterans Healthcare Administration (VHA) and is frequently under-diagnosed. We developed the Veterans Airflow Screening Questionnaire (VAFOSQ) to improve the identification of Veterans with airflow obstruction (AFO), the most commonly used criterion for the diagnosis of COPD.We created an initial survey with 78 variables that have been associated with AFO. A total of 825 patients in 3 primary care clinics performed spirometry after bronchodilator administration and completed the initial survey. Best sets regression was used to build a model that predicted AFO optimally. A total of 195 of 825 (23.3%) patients had AFO and 7 items positively predicted AFO. When the questionnaire score was greater than 25, the VAFOSQ accurately identified AFO with an area under the receiver operating curve of 0.72. In a prospective validation cohort of 376 participants, the positive predictive value was 32% and negative predictive value 81%. The VAFOSQ is a reliable and valid instrument for the identification of veterans at risk for AFO who would benefit from further evaluation with spirometry and assessment for COPD. The VAFOSQ is straightforward to use and can be easily self-administered and self-scored enabling widespread application within the VHA.

Entities:  

Keywords:  chronic obstructive pulmonary disease; copd; screening questionnaire

Year:  2016        PMID: 28848897      PMCID: PMC5556954          DOI: 10.15326/jcopdf.3.4.2016.0128

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  36 in total

Review 1.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

Review 2.  COPD: early diagnosis and treatment to slow disease progression.

Authors:  T Welte; C Vogelmeier; A Papi
Journal:  Int J Clin Pract       Date:  2014-10-31       Impact factor: 2.503

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD.

Authors:  Bridget F Collins; Laura C Feemster; Seppo T Rinne; David H Au
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

5.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy.

Authors:  G Caramori; G Bettoncelli; R Tosatto; F Arpinelli; G Visonà; G Invernizzi; B F Novelletto; A Papi; I M Adcock; A Ciaccia
Journal:  Monaldi Arch Chest Dis       Date:  2005-03

Review 7.  Screening for and early detection of chronic obstructive pulmonary disease.

Authors:  Joan B Soriano; Jan Zielinski; David Price
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

8.  The silence of patients with end-stage COPD: a qualitative study.

Authors:  Jolanda M Habraken; Jeannette Pols; Patrick J E Bindels; Dick L Willems
Journal:  Br J Gen Pract       Date:  2008-12       Impact factor: 5.386

9.  Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.

Authors:  W M Vollmer; Thorn Gíslason; P Burney; P L Enright; A Gulsvik; A Kocabas; A S Buist
Journal:  Eur Respir J       Date:  2009-05-21       Impact factor: 16.671

Review 10.  Health and social impacts of COPD and the problem of under-diagnosis.

Authors:  Stefano Carlone; Bruno Balbi; Michela Bezzi; Marco Brunori; Stefano Calabro; Maria Pia Foschino Barbaro; Claudio Micheletto; Salvatore Privitera; Roberto Torchio; Pietro Schino; Andrea Vianello
Journal:  Multidiscip Respir Med       Date:  2014-12-06
View more
  1 in total

1.  Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients.

Authors:  Amr Shaaban Hanafy; Waseem M Seleem; Hany A Elkattawy
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 5.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.